Cerulean Pharma (CERU) Releases Quarterly Earnings, Beats Estimates By $0.02 EPS
Cerulean Pharma (NASDAQ:CERU) posted its quarterly earnings results on Wednesday. The company reported ($0.34) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.36) by $0.02, AnalystRatingsNetwork reports.
Shares of Cerulean Pharma (NASDAQ:CERU) opened at 3.46 on Wednesday. Cerulean Pharma has a 52-week low of $3.35 and a 52-week high of $8.06. The stock has a 50-day moving average of $4.85 and a 200-day moving average of $5.82. The company’s market cap is $69.6 million.
Cerulean Pharma Inc is a clinical-stage oncology-focused company applying its tumor targeting platform.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.